Literature DB >> 2899378

Do concentrations of neurotransmitters measured in lumbar cerebrospinal fluid reflect the concentrations at brain level?

A Gjerris1, F Gjerris, P S Sørensen, E B Sørensen, N J Christensen, J Fahrenkrug, J F Rehfeld.   

Abstract

CSF concentrations of vasoactive intestinal polypeptide (VIP), cholecystokinin (CCK), noradrenaline (NA) and dopamine (DA) were measured in the lateral ventricles and at the lumbar level in patients with normal pressure hydrocephalus (NPH). The concentrations of VIP (n = 15), NA (n = 10) and DA (n = 10) were significantly higher at the lumbar level than at the ventricular level, whereas the concentrations of CCK (n = 9) were similar at the two sites. A significant positive correlation between the concentrations measured at the two levels was found for VIP (rs = 0.65; p less than or equal to 0.01) and DA (rs = 0.94; p less than or equal to 0.001). The results indicate that the concentrations of transmitter substances measured in CSF at the lumbar level not necessarily are indicative for concentrations measured more centrally. The negative correlations between Evans ratio and L-CSF VIP (rs = -0.76; p less than or equal to 0.001), and between resistance to outflow and V-CSF as well as L-CSF CCK (rs = -0.75); p less than or equal to 0.05) might be explained by a reduction in number of cortical neurons or by disturbances in CSF dynamics in patients with NPH.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899378     DOI: 10.1007/bf01400529

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  26 in total

1.  CSF-amine metabolites in depression, dementia and in controls.

Authors:  A Gjerris; L Werdelin; F Gjerris; P S Sørensen; O J Rafaelsen; C Alling
Journal:  Acta Psychiatr Scand       Date:  1987-06       Impact factor: 6.392

2.  Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema.

Authors:  N J Christensen
Journal:  Clin Sci Mol Med       Date:  1973-08

Review 3.  Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.

Authors:  A T Moir; G W Ashcroft; T B Crawford; D Eccleston; H C Guldberg
Journal:  Brain       Date:  1970       Impact factor: 13.501

4.  On the cerebral origin of 5-hydroxyindoleacetic acid in the lumbar cerebrospinal fluid.

Authors:  M Bulat
Journal:  Brain Res       Date:  1977-02-18       Impact factor: 3.252

5.  Site of lumbar puncture influences levels of monoamine metabolites.

Authors:  C Nordin; B Siwers; L Bertilsson
Journal:  Arch Gen Psychiatry       Date:  1982-12

Review 6.  Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function.

Authors:  J Fahrenkrug
Journal:  Digestion       Date:  1979       Impact factor: 3.216

7.  Monoamine acid metabolites and cerebrospinal fluid dynamics in normal pressure hydrocephalus: preliminary results.

Authors:  G Maira; S R Bareggi; C Di Rocco; G Calderini; P L Morselli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-02       Impact factor: 10.154

8.  The predictive value of conductance to outflow of CSF in normal pressure hydrocephalus.

Authors:  S E Børgesen; F Gjerris
Journal:  Brain       Date:  1982-03       Impact factor: 13.501

9.  Amine metabolites in human cerebrospinal fluid: effects of cord transection and spinal fluid block.

Authors:  R M Post; F K Goodwin; E Gordon; D M Watkin
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

10.  Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls.

Authors:  L Bertilsson; M Asberg; O Lantto; G P Scalia-Tomba; L Träskman-Bendz; G Tybring
Journal:  Psychiatry Res       Date:  1982-02       Impact factor: 3.222

View more
  6 in total

1.  CSF beta-endorphin levels in patients with infantile autism.

Authors:  S Nagamitsu; T Matsuishi; T Kisa; H Komori; M Miyazaki; T Hashimoto; Y Yamashita; E Ohtaki; H Kato
Journal:  J Autism Dev Disord       Date:  1997-04

2.  Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus.

Authors:  M A Poca; M Mataró; J Sahuquillo; R Catalán; J Ibañez; R Galard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

Review 3.  VIP: molecular biology and neurobiological function.

Authors:  I Gozes; D E Brenneman
Journal:  Mol Neurobiol       Date:  1989       Impact factor: 5.590

4.  Alterations in perivascular dilatory neuropeptides (CGRP, SP, VIP) in the external jugular vein and in the cerebrospinal fluid following subarachnoid haemorrhage in man.

Authors:  R Juul; H Hara; S E Gisvold; A O Brubakk; T A Fredriksen; G Waldemar; J F Schmidt; R Ekman; L Edvinsson
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

5.  Biomarkers in chronic adult hydrocephalus.

Authors:  Andrew Tarnaris; Laurence D Watkins; Neil D Kitchen
Journal:  Cerebrospinal Fluid Res       Date:  2006-10-04

6.  Increased Vascular Endothelial Growth Factor in the Ventricular Cerebrospinal Fluid as a Predictive Marker for Subsequent Ventriculoperitoneal Shunt Infection : A Comparison Study among Hydrocephalic Patients.

Authors:  Jeong-Hyun Lee; Dong-Bin Back; Dong-Hyuk Park; Yoo-Hyun Cha; Shin-Hyuk Kang; Jung-Keun Suh
Journal:  J Korean Neurosurg Soc       Date:  2012-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.